$42.67
-0.0400 (-0.0937%)
At Close: Jun 23, 2026
Dow heads for fifth straight week of losses as uncertainty about Russia-Ukraine war remains
04:03pm, Friday, 11'th Mar 2022 Kwhen FinanceThinking about trading options or stock in Occidental Petroleum, Docusign, NVIDIA, General Electric, or Alibaba?
03:50pm, Friday, 11'th Mar 2022 Benzinga
NEW YORK , March 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OXY, DOCU, NVDA, GE, and BABA. … Full story available on Benzinga.com
Investors Ditching Safe Havens In Favor Of Small-Cap Stocks
02:59pm, Friday, 11'th Mar 2022 Benzinga
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Friday Market Open) Equity index futures are pointing to a higher open on Friday morning as Russian President Vladimir Putin said that there was a positive shift in talks with Ukraine despite reports of talks breaking down on Thursday. The news prompted the S&P 500 futures to test the 4,300 resistance level. As always in these situations, watch the first 30 minutes to see if the Market can hold those gains. While the news story is developing, uncertainty around the market appears to be easing. The Market Volatility Index (VIX) has fallen below the 30 level. Additionally, gold futures were trading 1.5% lower in premarket action, suggesting some investors are leaving safe havens. Investors may be in search of riskier assets because the Russell 2000 futures were up 1.42% before the opening bell. Considering these developments in light of the selloff in Treasuries the last three days, investors may be in a buying mood going into the weekend.
Why DocuSign Shares Continue To Slide Today
02:47pm, Friday, 11'th Mar 2022 Benzinga
DocuSign Inc (NASDAQ: DOCU ) shares are sliding Friday morning after several analysts downgraded or lowered price targets on the stock. DocuSign shares were falling after hours Thursday following the company''s financial results and weak guidance. DocuSign said it expects first-quarter revenue to be between $579 million and $583 million versus the $594 million estimate. The company expects full fiscal year 2023 revenue to be between $2.47 billion and $2.482 billion versus the $2.61 billion estimate. Analyst Assessment: Citigroup analyst Tyler Radke maintained DocuSign with a … Full story available on Benzinga.com
Is DOCU Stock a Buy After 20% Plunge? 3 Analysts Weigh In on DocuSign Prices.
10:32am, Friday, 11'th Mar 2022
DocuSign is stumbling after sharing that Covid-19-driven demand for its products and services is waning. DOCU stock is taking a hit.
Why DocuSign Shares Continue To Slide Today
09:47am, Friday, 11'th Mar 2022
DocuSign Inc (NASDAQ: DOCU) shares are sliding Friday morning after several analysts downgraded or lowered price targets on the stock. DocuSign shares were falling after hours Thursday following the c
Rivian's Down Again, but This Nasdaq SaaS Stock Is Falling Harder
08:27am, Friday, 11'th Mar 2022
The Nasdaq looked set to rebound on Friday morning.
DocuSign (DOCU) Q4 2022 Earnings Call Transcript
02:00am, Friday, 11'th Mar 2022 The Motley Fool
DOCU earnings call for the period ending December 31, 2021.
DocuSign, Inc. (DOCU) CEO Daniel Springer on Q4 2022 Results - Earnings Call Transcript
01:48am, Friday, 11'th Mar 2022 Seeking AlphaStock futures are flat as Dow heads for fifth straight losing week amid Russia-Ukraine war
12:05am, Friday, 11'th Mar 2022 Kwhen FinanceBenzinga''s After-Hours Movers & News: DocuSign, Clearside Biomedical And More
10:50pm, Thursday, 10'th Mar 2022 Benzinga
Benzinga''s “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro''s Movers tool. Benzinga Pro users can cross-reference the Movers tool with the Benzinga Pro News tool to identify potential news catalysts moving stocks. See Also: Markets Have Mixed Day Of Trading As Russia-Ukraine Ceasefire Talks Go Nowhere Movers Lucria Health (NASDAQ: LHDX ) +16.86%: Reported net revenue of $61.1 million for the fourth quarter of 2021, representing approximately 300% growth over the last quarter. Recorded full-year revenue of $93.1 million for 2021 Clearside Biomedical (NASDAQ: CLSD ) +34%: Reported quarterly earnings of $0.31 per share, which beat the analyst consensus estimate of $0.16 by … Full story available on Benzinga.com
Stocks making the biggest moves after hours: Rivian, Oracle, DocuSign and more
10:19pm, Thursday, 10'th Mar 2022 CNBC
See which stocks are posting big moves after the bell.
DocuSign Stock Tumbles as Outlook Again Falls Short
10:19pm, Thursday, 10'th Mar 2022 Barron''s
It was the second quarter in a row that forecasts by the digital-signature company have fallen short of Street estimates and spurred a selloff in the stock.
DocuSign Stock Tumbles As Fiscal 2023 Revenue Guidance Misses Estimates
09:25pm, Thursday, 10'th Mar 2022 Investor''s Business Daily
DocuSign stock plunged after its January-quarter earnings met estimates and revenue topped views while guidance fell short.
Sign In
Buy DOCU